GlassScriptPhysician profile
Rebecca Lee Weber
NPI 1548267354
$1,979.60
in general payments reported to CMS, 2019-2025
27 companies · $304 in 2025
The $304 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $97.15 · 2021: $512 · 2022: $309 · 2023: $382 · 2024: $219 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $906.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $905.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $335.63 | 2023-2025 | Myfembree |
| Abbvie INC. | $265.04 | 2019-2021 | |
| Organon LLC | $168.09 | 2021-2024 | Nuvaring, Nexplanon |
| Exeltis, USA INC. | $141.74 | 2021-2025 | Slynd |
| Coopersurgical, INC. | $100.30 | 2019-2024 | Paragard T 380a |
| Millicent US INC | $95.61 | 2023-2025 | Intrarosa, Femlyv, Femring |
| Mayne Pharma Commercial LLC | $85.33 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $81.26 | 2019-2023 | Gardasil 9 |
| Daiichi Sankyo INC. | $74.13 | 2019-2024 | Injectafer |
| Astellas Pharma US INC | $73.86 | 2024-2025 | Veozah |
| Hologic Sales and Service, LLC | $61.88 | 2022-2023 | Affirm Prone Biopsy System, Thinprep 2000 Processor, Aptima |
| Therapeuticsmd, INC. | $54.21 | 2020-2022 | |
| Smith+Nephew, INC. | $50.21 | 2024 | Pico |
| Evofem Biosciences, INC. | $45.88 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $45.77 | 2021-2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $40.35 | 2021 | |
| Davol INC. | $34.87 | 2024 | Progel Applicator Spray Tips |
| Mylan Pharmaceuticals INC. | $34.55 | 2022 | |
| Amag Pharmaceuticals, INC. | $26.73 | 2019 | |
| Vivus LLC | $25.11 | 2019 | |
| Myovant Sciences INC. | $23.25 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $22.59 | 2021 | |
| Scynexis, INC. | $21.77 | 2022 | |
| Biogen, INC. | $21.68 | 2025 | Zurzuvae |
| Pfizer INC. | $20.53 | 2023 | |
| Agile Therapeutics, INC. | $15.95 | 2023 | Twirla |
| Novo Nordisk INC | $13.28 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rebecca Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.